Sugammadex Use for Reversal in Nonobstetric Surgery During Pregnancy: A Reexamination of the Evidence

Anesth Analg. 2023 Jun 1;136(6):1217-1219. doi: 10.1213/ANE.0000000000006442. Epub 2023 May 19.

Authors

Ian N Gaston¹, Elizabeth M S Lange², Jason R Farrer¹, Paloma Toledo^{1

3}

Affiliations

¹ From the Department of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
² Department of Anesthesiology, Emory University School of Medicine, Atlanta, Georgia.
³ Department of Anesthesiology, University of Miami Miller School of Medicine, Miami, Florida.

PMID: 37205805
DOI: 10.1213/ANE.0000000000006442

No abstract available

Publication types

Research Support, U.S. Gov't, P.H.S.
Research Support, Non-U.S. Gov't

MeSH terms

Female
Humans
Neostigmine
Neuromuscular Blockade*
Neuromuscular Nondepolarizing Agents*
Pregnancy
Rocuronium
Sugammadex

Substances

Sugammadex
Rocuronium
Neuromuscular Nondepolarizing Agents
Neostigmine

Grants and funding